195 related articles for article (PubMed ID: 28475811)
21. Monoclonal antibodies to growth hormone (GH) prolong liver GH binding and GH-induced IGF-I/IGFBP-3 synthesis.
Beauloye V; Muaku SM; Lause P; Portetelle D; Renaville R; Robert AR; Ketelslegers JM; Maiter D
Am J Physiol; 1999 Aug; 277(2):E308-15. PubMed ID: 10444427
[TBL] [Abstract][Full Text] [Related]
22. Role of GH and IGF-I in the regulation of IGF-I, IGF-I receptor and IGF binding protein gene expression in the rat spleen.
Domené HM; Meidan R; Yakar S; Shen-Orr Z; Cassorla F; Roberts CT; LeRoith D
Regul Pept; 1994 Aug; 52(3):215-26. PubMed ID: 7528435
[TBL] [Abstract][Full Text] [Related]
23. A model for tissue-specific inducible insulin-like growth factor-I (IGF-I) inactivation to determine the physiological role of liver-derived IGF-I.
Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
Endocrine; 2002 Dec; 19(3):249-56. PubMed ID: 12624424
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice.
Brooks NE; Hjortebjerg R; Henry BE; List EO; Kopchick JJ; Berryman DE
Growth Horm IGF Res; 2016; 30-31():22-30. PubMed ID: 27585733
[TBL] [Abstract][Full Text] [Related]
25. Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis.
Venken K; Schuit F; Van Lommel L; Tsukamoto K; Kopchick JJ; Coschigano K; Ohlsson C; Movérare S; Boonen S; Bouillon R; Vanderschueren D
J Bone Miner Res; 2005 Dec; 20(12):2138-49. PubMed ID: 16294267
[TBL] [Abstract][Full Text] [Related]
26. Influence of hypothalamus and ovary on pituitary function in transgenic mice expressing the bovine growth hormone gene and in growth hormone-deficient Ames dwarf mice.
Chandrashekar V; Bartke A
Biol Reprod; 1996 May; 54(5):1002-8. PubMed ID: 8722619
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibodies to bovine growth hormone potentiate hormonal activity in vivo by enhancing growth hormone binding to hepatic somatogenic receptors.
Massart S; Maiter D; Portetelle D; Adam E; Renaville R; Ketelslegers JM
J Endocrinol; 1993 Dec; 139(3):383-93. PubMed ID: 8133207
[TBL] [Abstract][Full Text] [Related]
28. Influence of nutrition and bovine growth hormone (GH) on hepatic GH binding, insulin-like growth factor-I and growth of lambs.
Bass JJ; Oldham JM; Hodgkinson SC; Fowke PJ; Sauerwein H; Molan P; Breier BH; Gluckman PD
J Endocrinol; 1991 Feb; 128(2):181-6. PubMed ID: 2005409
[TBL] [Abstract][Full Text] [Related]
29. Deficiency of the insulin-like growth factor-binding protein acid-labile subunit (ALS) of the circulating ternary complex in children with short stature.
Domené HM; Scaglia PA; Jasper HG
Pediatr Endocrinol Rev; 2010 Jun; 7(4):339-46. PubMed ID: 20679994
[TBL] [Abstract][Full Text] [Related]
30. Nutritional regulation of the genes encoding the acid-labile subunit and other components of the circulating insulin-like growth factor system in the sheep.
Rhoads RP; Greenwood PL; Bell AW; Boisclair YR
J Anim Sci; 2000 Oct; 78(10):2681-9. PubMed ID: 11048934
[TBL] [Abstract][Full Text] [Related]
31. Actions and interactions of growth hormone and insulin-like growth factor-II: body and organ growth of transgenic mice.
Blackburn A; Schmitt A; Schmidt P; Wanke R; Hermanns W; Brem G; Wolf E
Transgenic Res; 1997 May; 6(3):213-22. PubMed ID: 9167269
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of maternal ovine placental lactogen and growth hormone (GH) administration on GH receptor, insulin-like growth factor (IGF)-1 and IGF binding protein-3 gene expression in the pregnant and fetal sheep.
Currie MJ; Bassett NS; Breier BH; Klempt M; Min SH; Mackenzie DD; McCutcheon SN; Gluckman PD
Growth Regul; 1996 Sep; 6(3):123-9. PubMed ID: 8894644
[TBL] [Abstract][Full Text] [Related]
33. Mice overexpressing growth hormone exhibit increased skeletal muscle myostatin and MuRF1 with attenuation of muscle mass.
Consitt LA; Saneda A; Saxena G; List EO; Kopchick JJ
Skelet Muscle; 2017 Sep; 7(1):17. PubMed ID: 28870245
[TBL] [Abstract][Full Text] [Related]
34. Continuous administration of growth hormone does not prevent the decrease of IGF-I gene expression in zinc-deprived rats despite normalization of liver GH binding.
Ninh NX; Maiter D; Lause P; Chrzanowska B; Underwood LE; Ketelslegers JM; Thissen JP
Growth Horm IGF Res; 1998 Dec; 8(6):465-72. PubMed ID: 10985758
[TBL] [Abstract][Full Text] [Related]
35. Chronic alterations in growth hormone/insulin-like growth factor-I signaling lead to changes in mouse tendon structure.
Nielsen RH; Clausen NM; Schjerling P; Larsen JO; Martinussen T; List EO; Kopchick JJ; Kjaer M; Heinemeier KM
Matrix Biol; 2014 Feb; 34():96-104. PubMed ID: 24080228
[TBL] [Abstract][Full Text] [Related]
36. Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice.
Chen NY; Chen WY; Bellush L; Yang CW; Striker LJ; Striker GE; Kopchick JJ
Endocrinology; 1995 Feb; 136(2):660-7. PubMed ID: 7835300
[TBL] [Abstract][Full Text] [Related]
37. Alcohol suppresses insulin-like growth factor-1 gene expression in prepubertal transgenic female mice overexpressing the bovine growth hormone gene.
Srivastava VK; Dearth RK; Hiney JK; Chandrashekar V; Mattison JA; Bartke A; Dees WL
Alcohol Clin Exp Res; 2002 Nov; 26(11):1697-702. PubMed ID: 12436059
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor I (IGF-I) replacement during growth hormone receptor antagonism normalizes serum IGF-binding protein-3 and markers of bone formation in ovariectomized rhesus monkeys.
Wilson ME
J Clin Endocrinol Metab; 2000 Apr; 85(4):1557-62. PubMed ID: 10770197
[TBL] [Abstract][Full Text] [Related]
39. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone.
Yakar S; Bouxsein ML; Canalis E; Sun H; Glatt V; Gundberg C; Cohen P; Hwang D; Boisclair Y; Leroith D; Rosen CJ
J Endocrinol; 2006 May; 189(2):289-99. PubMed ID: 16648296
[TBL] [Abstract][Full Text] [Related]
40. The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children.
Mandel SH; Moreland E; Rosenfeld RG; Gargosky SE
Endocrine; 1997 Dec; 7(3):351-60. PubMed ID: 9657073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
